Skip to main content
  • COVID-19
    • COVID-19 vaccines and cancer
      • FAQs
      • FAQs in-language
      • SerOzNET Study
    • COVID-19 information for people affected by cancer
      • Managing your cancer care in the context of COVID-19
      • Looking after your mental wellbeing
      • Canada
      • Ireland
      • UK
      • USA
    • COVID-19 information for children and young people with cancer
    • Cancer Won’t Wait
    • Cancer and COVID-19 - what it means for our Mob
      • COVID-19 vaccines: Information for Aboriginal and Torres Strait Islander people affected by cancer
      • Act early for our Mob's health
    • Guidance for health professionals
      • Diagnosis
      • Treatment
      • Surgery
      • Medical oncology
      • Radiation oncology
      • Primary care
      • Telehealth
      • Clinical trials
      • Follow-up care
      • Supportive and Palliative care
      • Cancer care for cancer patients with COVID-19
      • COVID-19 vaccines and cancer
      • Recovery
    • Research articles
      • Review articles
      • Data articles
      • Recommendations articles
      • Shared experience articles
      • COVID-19 vaccines and cancer articles
    • Cancer care in the time of COVID-19: A conceptual framework
    • Optimal cancer care during the COVID-19 pandemic: the Principles
    • The impact of COVID-19 on cancer services
    • COVID-19 Recovery: Implications for cancer care
      • Expanded use of telehealth
      • Changes to prevention and early detection
      • Virtual multidisciplinary team meetings
      • Modifications to treatment schedules
      • Hypofractionated radiotherapy
      • Oncology hospital in the home
      • Responsive patient support
      • Innovative care and hospital infrastructure models
      • Shared follow-up and survivorship care
      • Supportive and palliative care
      • Cancer research and clinical trials
      • Collaboration in the oncology sector and data sharing
      • Acknowledgements
  • About us
    • Organisational structure
    • Accountability and reporting
      • Annual reports
    • Who we work with
      • Roles & functions
      • Advisory Council
      • Advisory groups
      • Consumer engagement
      • Government cancer control organisations
    • Information publication scheme
      • Information publication scheme plan
      • Freedom of information act
        • The FOI request process
      • FOI disclosure log
    • Reconciliation action plan
    • Employment opportunities
  • News and media
    • News
    • Subscribe to our eNewsletter
  • Contact us
Cancer Australia
Choose Language
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • Home
  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives
  • Home
  • Cancer types
    • Bladder cancer
    • Bowel cancer
    • Brain cancer
    • Breast cancer
    • Breast cancer in men
    • Breast cancer in young women
    • Cervical cancer
    • Children’s cancer
    • Endometrial cancer
    • Fallopian cancer
    • Gestational trophoblastic disease
    • Gynaecological cancers
    • Head and neck cancer
    • Kidney cancer
    • Leukaemia
    • Liver cancer
    • Lung cancer
    • Lymphoma
    • Melanoma
    • Mesothelioma cancer
    • Myeloma
    • Neuroendocrine tumours
    • Oesophageal cancer
    • Ovarian cancer
    • Pancreatic cancer
    • Prostate cancer
    • Sarcoma
    • Stomach cancer
    • Testicular cancer
    • Thyroid cancer
    • Unknown primary cancer
    • Uterine sarcoma
    • Vaginal cancer
    • Vulvar cancer
  • Impacted by Cancer
    • What is cancer
    • Physical changes
    • Treatment
    • Keeping healthy
    • Emotions
    • Family and relationships
    • Living with cancer
    • Guides to Best Cancer Care
    • Lynch Syndrome
  • Awareness
    • Your cancer risk
    • Screening
    • Interactive body map
  • Research
    • Cancer Research in Australia
    • Data and statistics
    • Australian Clinical Trials
    • Support for cancer clinical trials
    • Grants and funding
  • Resources
    • Cancer Australia Publications
    • Clinical Practice Guidelines
    • Position statements
    • Resources in other languages
    • Cancer Australia websites
    • Cancer risk online assessment tools
    • Other tools and resources
    • Podcasts
    • Cancer support organisations
    • Glossary
  • Clinicians hub
    • GP guides and resources
    • Guidelines by cancer type
    • Optimal Care Pathways
    • Working with Aboriginal and Torres Strait Islander people
    • Multidisciplinary care
    • Psychosocial care
    • Follow-up care
    • Family cancer clinics
    • Cancer Learning
    • Consumer engagement
  • Key initiatives
    • For Aboriginal and Torres Strait Islander people
    • Australian Cancer Plan
    • Australian Brain Cancer Mission
    • Lung Cancer Screening
    • National Pancreatic Cancer Roadmap
    • Campaigns & events
    • Jeannie Ferris Recognition Award

Vulval cancer

vulval-mm cancer-types/vulval-cancer/overview
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Diagnosis
      • Staging and grading
      • VIN
    • Treatment
      • Effects on fertility
    • Living with
      • Physical changes
      • Emotional changes
    • Life after
    • Finding support
    • Clinical trials
    • Health professionals
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Diagnosis
      • Staging and grading
      • VIN
    • Treatment
      • Effects on fertility
    • Living with
      • Physical changes
      • Emotional changes
    • Life after
    • Finding support
    • Clinical trials
    • Health professionals
  1. Home
  2. Treatment
  • Effects on fertility
Loading...

Treatment options

  • Printer-friendly version
  • A|A

Treatment and care of people with cancer is usually provided by a team of health professionals, both medical and allied health, called a multidisciplinary team.

Treatment for vaginal cancer depends on:

  • the type of vaginal cancer
  • where it is in the body
  • whether the cancer has spread, and where it has spread to
  • your general health
  • your personal preferences.

Treatment options include surgery, chemotherapy and radiation therapy.

Surgery

Surgery is the main treatment for vulvar cancer. It may be used either alone or in combination with radiotherapy and chemotherapy. Your doctor will talk to you about the most appropriate type of surgery.

There are several different operations for cancer of the vulva. Which operation you have usually depends on the stage of the cancer. The surgeon will aim to remove the cancer while preserving as much normal tissue as possible. However, it is important that a margin of healthy tissue around the cancer is removed, to reduce the risk of the cancer coming back (recurring) in this area.

Usually only a small amount of unaffected skin is removed with the cancer, so it is often possible to stitch the remaining skin neatly together. If it is necessary to remove a large area of skin, reconstructive surgery is available using a skin graft or skin flaps. To do this, the surgeon may take a thin piece of skin (graft) from another part of the body (usually the thigh or abdomen) and stitch it onto the operation site. It may be possible to move (rotate) flaps of skin in the vulval area to cover the wound. The graft or flaps will be done straight after the cancer is removed, as part of the same operation.

Local excision

Wide local excision takes out the cancer and a border (margin) of healthy cells, ideally at least 1 centimetre, all around the cancer.

Radical local excision takes out the cancer and a larger area of normal tissue all around the cancer. The groin lymph nodes may also be removed (known as lymph node dissection).

Vulvectomy

A partial vulvectomy removes part of the vulva.

A radical vulvectomy removes the entire vulva, including the clitoris and, usually, the surrounding lymph nodes.

Pelvic exenteration

Pelvic exenteration is usually only used for recurrent vulvar cancer that has come back even after radiation therapy.

Pelvic exenteration is surgery to remove the lower colon, rectum and bladder. In women, the cervix, vulva, vagina, ovaries and nearby lymph nodes are also removed. Openings called stoma are made to bring the small or large intestine out onto the abdomen. This allows urine and faeces to flow from inside the body to a collection bag.

Common stoma include:

  • an ileostomy (formed from the lower half of the small bowel, called the ileum, which joins up with the colon)
  • a colostomy (formed from the colon)
  • an ideal conduit (formed by isolating a small piece of ileum and implanting the tubes from the kidney – the ureters – into it).

For more information about adapting to life with a stoma, ask your treatment team or contact your local stoma association.

Plastic surgery to reconstruct the vulva and vagina may also be needed after pelvic exenteration.

Lymph nodes

The lymph nodes (also called lymph glands) in the groin are usually the first place to which vulvar cancer spreads. Lymph nodes are part of the lymphatic system, and are found mainly in the groin, neck and armpits.

If the vulvar cancer is small, some surgeons perform a procedure called a sentinel lymph node biopsy. This involves giving an anaesthetic, then injecting a radioactive dye into the cancer. The aim of a sentinel node biopsy is to identify the first node to which the cancer might spread. If the cancer has spread to a lymph node, the node will take up the dye, allowing the surgeon to locate and remove it. This surgical technique is still being refined.

If the cancer is deeper than 1 millimetre, you will usually be advised to have the lymph glands from one or both sides of your groin removed. This is done to check whether any cancer cells have spread from the vulva. If your cancer is at the very earliest stage, surgery to your lymph nodes will probably not be needed.

Radiation therapy

Radiation therapy is a commonly used treatment for vulvar cancer. In some women, radiation therapy may be combined with chemotherapy before surgery to help shrink the tumour.

You might have external radiation therapy to your pelvic area to treat vaginal cancer. Radiation therapy may also be recommended if the cancer has come back (recurrent cancer) or spread.

Chemotherapy

In women with vulvar cancer, chemotherapy is mainly used if the cancer has spread, or if the cancer returns after treatment (recurrent cancer). It may also be used with radiation therapy before surgery to help shrink the tumour.

Recurrent or advanced disease

Recurrent vulvar cancer is cancer that has recurred (come back) after it has been treated.

Recurrence is when the cancer comes back in the same part of the body. Secondary cancer is when the cancer spreads to another part of the body.

Vulvar cancer may recur in the vulva, the groin, the pelvis or elsewhere in the body.

Treatment of recurrent vulvar cancer will depend very much on the site (location) of the recurrence. It may involve surgical removal of the recurrence followed by radiotherapy, or radiotherapy by itself or with chemotherapy. These choices have to be made on an individual case-by-case basis.

A clinical trial of a new treatment may be possible.

Treating vulvar intraepithelial neoplasia (VIN)

Laser treatment or surgery may be used to remove the affected tissue.

If the VIN is close to the clitoris, care will be taken in the choice and extent of treatment.

Some doctors use chemotherapy drugs formulated into creams, which are applied topically (on the skin). These can cause a lot of inflammation and not all specialists support using them. Another topical treatment is a drug called imiquimod. It works by boosting your own immune response to the VIN. But this drug can cause pain and inflammation to the affected area as well.

Whatever treatment is given, careful follow-up is needed in case the VIN comes back.

  • Last Updated
  • Relevant Links
updated: 3 January 2023 - 2:24pm
American Cancer Society, Vulvar cancer
National Cancer Institute (US), Vulvar cancer treatment (PDQ®), patient version
Australian Cancer Trials

Related information

What is cancer?
What is cancer?

Cancer is a disease of the cells, which are the body’s basic building blocks.

Treatment and side effects
Treatment and side effects

The treatment that your doctors recommend will depend on the type of cancer you have, how advanced it is, and other personal factors.

Living with cancer
Living with cancer

A diagnosis of cancer marks the beginning of a journey full of emotional, psychological, physical and practical challenges.

Life after cancer
Life after cancer

While looking forward to finishing their cancer treatment and getting on with life, for some people, the end of treatment can also be a confusing or worrying time.

A-Z List of Cancer Types

Information on more than 70 types of cancer

  • Bladder cancer
  • Bowel cancer
  • Brain cancer
  • Breast cancer
  • Breast cancer in men
  • Breast cancer in young women
  • Cervical cancer
  • Children's Cancer
  • Endometrial cancer
  • Fallopian cancer
  • Gestational trophoblastic disease
  • Gynaecological cancers
  • Head and neck cancer
  • Kidney cancer
  • Leukaemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Melanoma of the skin
  • Mesothelioma cancer
  • Myeloma
  • Neuroendocrine tumours
  • Oesophageal cancer
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer
  • Sarcoma
  • Stomach cancer
  • Testicular cancer
  • Thyroid cancer
  • Unknown primary
  • Uterine sarcoma
  • Vaginal cancer
  • Vulval cancer

About Cancer Australia

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care.

If you would like an interpreter to help you understand any information on this website, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.

Freecall 1800 624 973
+61 2 9357 9400

Locked Bag 3, Strawberry Hills
NSW 2012

Navigation

  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives

Contact us

* Denotes mandatory fields
 

By submitting this form, you accept the Cancer Australia privacy policy.

  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy
  • Sitemap
Copyright © 2023 - Cancer Australia